2519 related articles for article (PubMed ID: 29046443)
1. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
2. Strain-Dependent Prion Infection in Mice Expressing Prion Protein with Deletion of Central Residues 91-106.
Uchiyama K; Miyata H; Yamaguchi Y; Imamura M; Okazaki M; Pasiana AD; Chida J; Hara H; Atarashi R; Watanabe H; Kondoh G; Sakaguchi S
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019549
[TBL] [Abstract][Full Text] [Related]
3. Central residues in prion protein PrP
Pasiana AD; Miyata H; Chida J; Hara H; Imamura M; Atarashi R; Sakaguchi S
J Biol Chem; 2022 Sep; 298(9):102381. PubMed ID: 35973512
[TBL] [Abstract][Full Text] [Related]
4. Mouse-hamster chimeric prion protein (PrP) devoid of N-terminal residues 23-88 restores susceptibility to 22L prions, but not to RML prions in PrP-knockout mice.
Uchiyama K; Miyata H; Yano M; Yamaguchi Y; Imamura M; Muramatsu N; Das NR; Chida J; Hara H; Sakaguchi S
PLoS One; 2014; 9(10):e109737. PubMed ID: 25330286
[TBL] [Abstract][Full Text] [Related]
5. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region.
Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S
Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632
[TBL] [Abstract][Full Text] [Related]
6. Biological and biochemical characterization of mice expressing prion protein devoid of the octapeptide repeat region after infection with prions.
Yamaguchi Y; Miyata H; Uchiyama K; Ootsuyama A; Inubushi S; Mori T; Muramatsu N; Katamine S; Sakaguchi S
PLoS One; 2012; 7(8):e43540. PubMed ID: 22927985
[TBL] [Abstract][Full Text] [Related]
7. Effects of prion protein devoid of the N-terminal residues 25-50 on prion pathogenesis in mice.
Das NR; Miyata H; Hara H; Uchiyama K; Chida J; Yano M; Watanabe H; Kondoh G; Sakaguchi S
Arch Virol; 2017 Jul; 162(7):1867-1876. PubMed ID: 28255815
[TBL] [Abstract][Full Text] [Related]
8. Strain-dependent role of copper in prion disease through binding to histidine residues in the N-terminal domain of prion protein.
Hara H; Miyata H; Chida J; Sakaguchi S
J Neurochem; 2023 Nov; 167(3):394-409. PubMed ID: 37777338
[TBL] [Abstract][Full Text] [Related]
9. Transgenic models of prion disease.
Scott MR; Supattapone S; Nguyen HO; DeArmond SJ; Prusiner SB
Arch Virol Suppl; 2000; (16):113-24. PubMed ID: 11214913
[TBL] [Abstract][Full Text] [Related]
10. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
Weissmann C
FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
[TBL] [Abstract][Full Text] [Related]
11. Guinea Pig Prion Protein Supports Rapid Propagation of Bovine Spongiform Encephalopathy and Variant Creutzfeldt-Jakob Disease Prions.
Watts JC; Giles K; Saltzberg DJ; Dugger BN; Patel S; Oehler A; Bhardwaj S; Sali A; Prusiner SB
J Virol; 2016 Nov; 90(21):9558-9569. PubMed ID: 27440899
[TBL] [Abstract][Full Text] [Related]
12. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
Moreno JA; Telling GC
Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
[TBL] [Abstract][Full Text] [Related]
13. Bovine spongiform encephalopathy in Japan: history and recent studies on oxidative stress in prion diseases.
Onodera T; Sakudo A; Wu G; Saeki K
Microbiol Immunol; 2006; 50(8):565-78. PubMed ID: 16924141
[TBL] [Abstract][Full Text] [Related]
14. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
15. Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice.
Espinosa JC; Andréoletti O; Castilla J; Herva ME; Morales M; Alamillo E; San-Segundo FD; Lacroux C; Lugan S; Salguero FJ; Langeveld J; Torres JM
J Virol; 2007 Jan; 81(2):835-43. PubMed ID: 17079295
[TBL] [Abstract][Full Text] [Related]
16. Prion encephalopathies of animals and humans.
Prusiner SB
Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
[TBL] [Abstract][Full Text] [Related]
17. Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies.
Priem J; Langeveld JP; van Keulen LJ; van Zijderveld FG; Andreoletti O; Bossers A
J Virol; 2014 Mar; 88(5):2903-12. PubMed ID: 24371051
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the PrPc Amino-Terminal Domain in Prion Species Barriers.
Davenport KA; Henderson DM; Mathiason CK; Hoover EA
J Virol; 2016 Dec; 90(23):10752-10761. PubMed ID: 27654299
[TBL] [Abstract][Full Text] [Related]
19. Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans.
Scott MR; Will R; Ironside J; Nguyen HO; Tremblay P; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15137-42. PubMed ID: 10611351
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation deficiency at either one of the two glycan attachment sites of cellular prion protein preserves susceptibility to bovine spongiform encephalopathy and scrapie infections.
Neuendorf E; Weber A; Saalmueller A; Schatzl H; Reifenberg K; Pfaff E; Groschup MH
J Biol Chem; 2004 Dec; 279(51):53306-16. PubMed ID: 15448157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
